epigenetics; quiescence; histone modifications EPIGENETICS REFERS TO THE processes that control heritable changes in gene expression that are not due to changes in the DNA sequence. Therefore, while the sequence of DNA bases is a centrally important determinant of a cell's properties, cells can confer information to their progeny through mechanisms in addition to the sequence of DNA bases. One example is that the DNA and the proteins with which it interacts, the chromatin, are modified without affecting its coding potential. For example, DNA can be modified through the addition of methyl groups at the C5 position of cytosine within CpG dinucleotides (20) . CpG dinucleotides occur frequently at mammalian promoter regions in "CpG islands," where hypermethylation often results in a more compact formation of the chromatin. By inhibiting the accessibility of chromatin to transcription factors, enhancers, and the transcriptional machinery, CpG methylation inhibits transcription initiation. Interestingly, thousands of so-called "orphan" CpG islands, intergenic or intragenic CpG islands distant from known promoters, have been recently identified within the human genome and represent ϳ50% of human CpG islands (19, 33) . Although their function is largely unknown, they have been hypothesized to function during development (19, 33) . When present near transcription start sites, promoter DNA methylation can modulate the expression of cell type-specific genes as cells differentiate during normal development. Promoter hypermethylation at CpG islands can silence tumor suppressor genes (28) , while global hypomethylation is associated with deregulated expression of tumor suppressors, activity of repetitive elements such as LINE and SINE, and consequently increased genomic instability and predisposition to tumor formation (14, 17) . Thus, CpG methylation can affect gene expression, genomic instability, and tumor susceptibility.
Modification of the DNA packaging proteins, the octamers of histones that form nucleosomes, in addition to the DNA itself, allows for more opportunities for the regulation of chromatin state and can thus affect gene expression and cellular state (30, 58) . The NH 2 -terminal tails of each histone are exposed to the nucleoplasm where they are susceptible to covalent modification. A wide range of posttranslational modifications have been identified, including mono-, di-, and trimethylation, acetylation, phosphorylation, ubiquitination, and others, each of which can affect the state of chromatin depending on the histone, modified amino acid, and position within the histone (2) . Changes in chromatin state that result from these different modifications of histones can alter DNA accessibility in order to modulate the recruitment of other histonemodifying enzymes and regulators of transcription (27) . For example, acetylation neutralizes the negative charge of lysine residues, thereby reducing internucleosomal interaction and promoting an open conformation that is accessible to transcription factor binding (29, 55) . These characteristics of CpG promoter methylation, and histone modifications associated with actively transcribed genes, have proved useful in identifying novel genes, such as noncoding RNAs (54) . Furthermore, interrogation of the epigenetic modifications associated with disease, together with transcriptional profiling experiments, has allowed for a more complete understanding of the processes underlying various disorders including diabetes (34), cardiomyopathy (24, 25) , and colorectal cancer (54) .
Epigenetics and Quiescence
Epigenetics has been shown to play a role in the commitment to proliferation or cell cycle arrest. The members of the retinoblastoma family act as a brake on the cell cycle, opposing cell cycle progression promoted by the E2F1-3 transcription factors. Retinoblastoma proteins repress transcription of cell cycle-promoting genes by recruiting the corepressor Sin3B, which in turn recruits the histone deacetylases 1 and 2 to the promoters of E2F target genes (8, 16, 43) . The histone deacetylases remove acetyl groups from histone lysines and make the chromatin in the promoters of E2F genes more compact, thus repressing transcriptional activation. Cells derived from mSin3b-deficient mice cycle normally under proliferative conditions but are unable to exit the cell cycle in response to limiting growth factors (8) . As another example, mixed lineage leukemia 5 (MLL5) is induced as myoblasts enter quiescence (49) . MLL5 mediates cell cycle arrest by increasing methylation of H3K4 in the promoter of the cyclin A gene, thus reducing cyclin A expression (49) . Cell cycle arrest in response to DNA damage can also be mediated through epigenetic changes. After an event that damages DNA, the ING2 protein recognizes and binds H3K4me3 marks in the cyclin D2 promoter (40, 50) , recruits the Sin3a-histone deacetylase 1 complex and silences cyclin D1 expression (50) . Thus, in response to quiescence signals or damaged DNA, epigenetic changes have been discovered to be important intermediates in signaling pathways that control proliferation.
Histone H4K20
Among the histone modifications that play a functional role in chromatin activity, our data led us to focus on lysine 20 of histone H4 (H4K20). Levels of singly methylated H4K20 are cell cycle dependent (1, 7, 21, 39, 41, 57) , and methylation of H4K20 has been implicated in cell cycle progression, chromosome condensation, transcription, and licensing of origins of replication (6, 18, 23, 39, 44, 51, 53) . PR-Set-7, an enzyme that generates monomethylated H4K20, H4K20me (12, 38) , is actively targeted for proteasome-mediated degradation in S phase (1, 21, 22, 44, 53, 57) and exhibits high activity during mitosis (57) . Dimethylated H4K20, H4K20me2, serves as a binding site for the DNA damage recognition protein 53BP1 and thereby facilitates repair of double strand breaks (5, 45) . H4K20me3 has been implicated in heterochromatin maintenance and is found at telomeres (3, 26, 31, 47) and repeated elements including transposable elements (32, 35, 36) . Deletion of Suv4-20h2 leads to longer telomeres (3) and induces the expression of transposons in Drosophila (42) . In humans and mice, H4K20me2 and H4K20me3 levels are regulated by a pair of closely related paralogs, Suv4-20h1 and Suv4-20h2. Deletion of Suv4-20h1 results in depletion of H4K20me2, while deletion of Suv4-20h2 results in depletion of H4K20me3 (48) .
Loss of H4K20me3 is a common hallmark of human cancer (13, 46, 56) . In a large panel of different types of cancer cells and in pairs of tumors and matched normal tissue, H4K20me3 levels were consistently low in cancer cells (13) . In lung and bladder cancer, H4K20me3 levels decreased with increasing tumor grade, and H4K20me3 levels predicted survival (46, 56) . Teratomas generated from induced pluripotent stem cells doubly deficient for Suv4-20h1 and Suv4-20h2 exhibit an enhanced growth rate compared with wild-type controls (31) .
H4K20 is Induced in Quiescence
Using a model of quiescence in primary human dermal fibroblasts, we monitored the extent of chromatin compaction using dual-color fluorescence in situ hybridization with probes for two loci on chromosome 16 to monitor the extent of chromatin compaction in collaboration with the Dyson lab (Massachusetts General Hospital). Contact-inhibited fibroblasts exhibited a smaller interprobe distance than proliferating or restimulated cells (10) . Thus, in primary human fibroblasts, entry into quiescence in response to contact inhibition resulted in more tightly packed chromatin that was reversibly unpacked upon cell cycle reentry. To quantitatively measure the changes in global histone modifications between proliferating and contact-inhibited fibroblasts, histones were analyzed by liquid chromatography-mass spectrometry in collaboration with Prof. Ben Garcia (University of Pennsylvania). Mass spectrometry allowed for a highly quantitative analysis of ϳ50 histone modifications in a single experiment. Surprisingly, after 14 or 21 days of contact inhibition, most histone modifications were present at similar levels in proliferating and quiescent fibroblasts (10, 11) . Out of the 48 modification states monitored, 44 exhibited less than a twofold change. The modification with the largest change in abundance among the states was H4K20, with an approximately eightfold induction in H4K20me3. Restimulation of quiescent cells resulted in a reduction in H4K20me3 levels. Our findings demonstrate that changes in the pattern of H4K20 methylation occur consistently in cells that have exited the proliferative cell cycle and that the changes are reversible in quiescent fibroblasts.
Knockdown of Suv4-20h2 Results in Loss of Compaction and Quiescence Entry
To further explore the importance of H4K20 in quiescence, we monitored the amount of compaction in cells with knockdown of Suv4-20h1 or Suv4-20h2 using siRNA pools that achieved an ϳ60% reduction in the levels of the targeted transcripts. The siRNA pool against Suv4-20h1 increased the distance between the foci but did not achieve statistical significance, whereas treatment with an siRNA pool against Suv4-20h2 resulted in a statistically significant increase in chromosome size (10) . We determined the effect of the knockdowns on proliferation and quiescence and discovered that the percentage of actively cycling cells was significantly higher for fibroblasts transfected with siRNAs directed against Suv4-20h2, but not Suv4-20h1, compared with a control set of siRNAs (10) . After contact inhibition, cell populations in which Suv4-20h2 was depleted also contained a greater fraction of cycling cells than controls (10) . While the fibroblasts initially exhibit a higher fraction of cells in S phase, when they were followed over time, cell number declined, which may reflect genomic instability associated with proliferation under conditions of inappropriate chromatin conformation. These findings indicate that not only do the levels of the higher methylated forms of H4K20 increase with quiescence, but that the methylation state of H4K20 may play a functional role in both chromatin compaction and the control of cell cycle progression. Fig. 1 . Models of the role of Suv4-20h2 in quiescence. Following entry into quiescence, levels of trimethylated H4K20 (H4K20me3) are elevated. Suv4-20h2 contains a SET domain that is responsible for H4K20 methyltransferase activity (red lines), as well as a COOH-terminal clamp domain that has been reported to regulate chromatin compaction in mouse embryonic fibroblasts (blue line). In primary human fibroblasts, Suv4-20h2 knockdown results in increased proliferation and reduced chromatin compaction. Further research will be required to determine whether H4K20me3 is directly involved in the compaction or proliferation phenotypes. Chromatin compaction and proliferation may reflect 2 independent Suv4-20h2 functions (dashed line), or chromatin compaction may regulate proliferation state either directly or via gene expression changes (dashed lines).
Suv4-20h2 Itself Interacts With Chromatin
One model consistent with our findings is that Suv4-20h2, through its effects on H4K20 methylation, modulates chromatin compaction, and that this results in cell cycle arrest. Another possible model is that Suv4-20h2 has two distinct functions, one that affects proliferation and another that influences chromatin compaction. Hahn et al. (15) in the Schotta laboratory recently reported that Suv4-20h2 itself stably binds heterochromatin. Suv4-20h1/2 double-knockout mouse embryonic fibroblasts have higher chromatin accessibility based on micrococcal nuclease digestion assays (15) . In investigating the portions of the Suv4-20h2 enzyme responsible for these effects, they discovered that the COOH-terminal clamp domain of Suv4-20h2, and not the NH 2 -terminal SET domain that encodes the methyltransferase activity, regulates the localization of Suv4-20h2 to heterochromatin and the effects of Suv4-20h2 on chromatin accessibility (15) . They further discovered that Suv4-20h2 mediates its compaction through interaction with a component of cohesin, a complex best known for its role connecting sister chromatids during cell division (15) . Importantly, in their work, the effects of Suv4-20h2 deletion on cohesin recruitment to heterochromatin were most obvious in cells that had exited the proliferative cell cycle.
Outstanding Questions for the Field
Taken together, our findings leave open several important questions. What is the functional role of the chromatin compaction that occurs during quiescence and what are its key mediators? More specifically, does Suv4-20h2 mediate the changes in chromatin compaction with quiescence, and are these effects a result of change in H4K20 methylation or do they reflect the direct interaction of Suv4-20h2 with heterochromatin ( Fig. 1) ? Are the changes in proliferation as a result of Suv4-20h2 knockdown a consequence of the changes in chromatin compaction? If so, is this effect mediated through changes in the expression of specific genes? And finally, do the chromatin compaction changes mediated by Suv4-20h2 affect a cell's propensity for tumorigenesis?
If changes in chromatin are sufficient to make cells more or less proliferative, then changes in the activity of these molecules, or changes in chromatin state, may be an important regulator of the transitions between proliferation and cell cycle arrest. Inappropriate proliferation, or a failure to proliferate when needed, may contribute to developmental disorders and to pathologies including cancer (4, 9, 52). Histone modifications are being intensively investigated as tumor markers and as targets for therapy (37) . A better understanding of the relationship between quiescence and epigenetics may provide important information about the approaches most likely to succeed in cancer therapies targeted to histone modifications.
